TALKING WITH YOUR HEALTHCARE TEAM

If you have HER2+ metastatic breast cancer, there are things you may want to ask your team

You can talk to someone you’re comfortable with on your healthcare team to help you understand your treatment plan. Here are some common questions to get you started.

Before starting treatment

What does “metastatic” or “advanced” breast cancer mean?
Is PERJETA-based treatment an appropriate treatment choice for my type of metastatic breast cancer?
How is PERJETA different from Herceptin^® (trastuzumab)?
How is PERJETA different from docetaxel?
How and when is PERJETA given?
What side effects might I experience with PERJETA-based treatment?

Preparing for treatment

What do I need to do to prepare for my infusions?
How do I find an infusion center?
Should I arrange for transportation to and from my infusion?
What should I bring with me to the infusion center?
How long do I need to receive PERJETA?
How long do I need to receive docetaxel?
Will I need to have a port for my infusion?

During treatment

How can my doctor and I tell if the treatment is working?
What side effects should I expect, and how severe might they be?
Are there things I can do to help with certain side effects?
How can I tell if the treatment is working?
How will I feel after these treatments?
Will my family be able to care for me after treatment?

Downloadable materials

Find additional information about HER2+ breast cancer and PERJETA.

Get resources

HERConnection Program

Enroll today

What does PERJETA treat?

PERJETA^® (pertuzumab) is approved for use in combination with Herceptin^® (trastuzumab) and docetaxel in people who have HER2-positive breast cancer that has spread to different parts of the body (metastatic) and who have not received anti-HER2 therapy or chemotherapy for metastatic breast cancer.

PERJETA^® (pertuzumab) is approved for use in combination with Herceptin^® (trastuzumab) and chemotherapy for:

use prior to surgery (neoadjuvant treatment) in people with HER2-positive, locally advanced, inflammatory, or early stage breast cancer (tumor is greater than 2 cm in diameter or node-positive). PERJETA should be used as part of a complete treatment regimen for early breast cancer.

use after surgery (adjuvant treatment) in people with HER2-positive early breast cancer that has a high likelihood of coming back.

What should I know about side effects with PERJETA?

Not all people have serious side effects; however, side effects with PERJETA therapy are common. It is important to know what side effects may happen and what symptoms you should watch for

Your doctor may stop treatment if serious side effects happen. Be sure to contact your healthcare team right away if you have questions or are worried about any side effects

What are the most serious side effects of PERJETA?

PERJETA may cause heart problems, including those without symptoms (such as reduced heart function) and those with symptoms (such as congestive heart failure).

Your doctor may run tests to monitor your heart function before and during treatment with PERJETA

Based on test results, your doctor may hold or discontinue treatment with PERJETA

Contact a health care professional immediately for any of the following: new onset or worsening shortness of breath, cough, swelling of the ankles/legs, swelling of the face, palpitations, weight gain of more than 5 pounds in 24 hours, dizziness or loss of consciousness

What are the most common side effects?

The most common side effects of PERJETA when given with Herceptin and docetaxel for treatment of breast cancer that has spread to other parts of the body (metastatic) are:

Diarrhea

Hair loss

Low levels of white blood cells with or without fever

Nausea

Feeling tired

Rash

Damage to the nerves (numbness, tingling, pain in hands/feet)

The most common side effects of PERJETA when given with Herceptin and chemotherapy as part of an early breast cancer regimen before surgery are:

Constipation

Damage to the nerves (numbness, tingling, pain in hands/feet)

Diarrhea

Feeling tired

Hair loss

Headache

Low levels of red blood cells

Low levels of white blood cells with or without fever

Low platelet count

Mouth blisters or sores

Nausea

Pain in the muscles

Vomiting

Weakness

Side effects may vary based on chemotherapy regimen.

The most common side effects of PERJETA when given with Herceptin and chemotherapy as part of an early breast cancer regimen after surgery are:

Diarrhea

Nausea

Hair Loss

Feeling tired

Damage to the nerves (numbness, tingling, pain in hands/feet)

Vomiting

TALKING WITH YOUR HEALTHCARE TEAM

If you have HER2+ metastatic breast cancer, there are things you may want to ask your team

Important Safety Information/Indication

What does PERJETA treat?

What should I know about side effects with PERJETA?

What are the most serious side effects of PERJETA?

What are other possible serious side effects?

What are the most common side effects?

TALKING WITH YOUR HEALTHCARE TEAM

If you have HER2+ metastatic breast cancer, there are things you may want to ask your team

Important Safety Information/Indication

What does PERJETA treat?

What should I know about side effects with PERJETA?

What are the most serious side effects of PERJETA?

What are other possible serious side effects?

What are the most common side effects?

Coming Soon